CompletedNCT00899899

Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Oncology Group
Principal Investigator
Richard Gorlick, MD
Children's Hospital at Montefiore
Intervention
microarray analysis(genetic)
Enrollment
135 target
Eligibility
120 years · All sexes
Timeline
19982006

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00899899 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials